Amedisys (NASDAQ:AMED) Hits New 12-Month Low – Here’s Why

Amedisys, Inc. (NASDAQ:AMED)’s share price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $83.73 and last traded at $83.78, with a volume of 910801 shares trading hands. The stock had previously closed at $84.97.

Amedisys Stock Performance

The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $2.77 billion, a P/E ratio of 33.52, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The company’s 50 day moving average is $91.75 and its 200-day moving average is $94.68.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the prior year, the business earned $0.98 earnings per share. The business’s quarterly revenue was up 5.7% on a year-over-year basis. As a group, equities analysts anticipate that Amedisys, Inc. will post 4.45 EPS for the current year.

Institutional Trading of Amedisys

Several hedge funds have recently bought and sold shares of AMED. KBC Group NV bought a new position in Amedisys in the 3rd quarter valued at about $63,000. Innealta Capital LLC purchased a new stake in shares of Amedisys in the second quarter worth approximately $64,000. Signaturefd LLC lifted its holdings in shares of Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after purchasing an additional 530 shares in the last quarter. CWM LLC lifted its holdings in shares of Amedisys by 14.5% in the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after purchasing an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new position in shares of Amedisys during the third quarter valued at approximately $243,000. Institutional investors and hedge funds own 94.36% of the company’s stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.